'Central lab' diaporamas de présentation

Laboratory Data Management

Laboratory Data Management. September, 2010 at SMMU, Shanghai. 1. 2. 4. Overview. Types of Laboratories. Standards. Agenda. 3. Lab Data Management. 5. Key Messages. 1. Overview. The vast majority of clinical studies use laboratory to provide: Safety Data

4.48k views • 50 slides

Acute HIV and the North Carolina STAT Project

538 views • 43 slides

Laboratory Information System

2.9k views • 35 slides

The Digital Pathology Experience at Intermountain Healthcare

593 views • 24 slides

Clinical trials

Clinical trials. Virtual tour Draft 2/19. Clinical Trials: Integrating with patient care. Adobe Berdy Medical Carefx CommerceNet DCRI Dictaphone Digital Infuzion Eclipsys Epic GE Medical Systems Heartlab IBM INFINITT Kodak Kryptiq Microsoft Misys Mortara NIST

293 views • 14 slides

Loading of Central Lab Data in CDISC LAB Standard

Loading of Central Lab Data in CDISC LAB Standard. Kurt Hellstern. Hands-on GmbH. Central Lab Database. Tabulator. SDTM. ODM. LAB (xml). Dataflow. Steps to Be Performed. Write specifications for the lab system extract file

271 views • 12 slides

Loading of Central Lab Data in CDISC LAB Standard

Loading of Central Lab Data in CDISC LAB Standard. Kurt Hellstern. Hands-on GmbH. Central Lab Database. Tabulator. SDTM. ODM. LAB (xml). Dataflow. Steps to Be Performed. Write specifications for the lab system extract file

205 views • 12 slides

Managing Clinical Supplies and Laboratories

Managing Clinical Supplies and Laboratories. Managing Supplies. The type of supplies that need to be managed can vary from study to study. Examples of study supplies. Forms Case Report Forms (CRFs) Informed Consent forms Worksheets/log sheets Serious Adverse Event Forms

261 views • 10 slides

Enhancing the value of the MDS registry by matching biobanking

Enhancing the value of the MDS registry by matching biobanking. Cells : Bone marrow mononuclear cells : DNA + RNA Peripheral blood mononuclear cells / granulocytes : DNA + RNA Buccal swap: DNA Serum Viable cells : none / only in dedicated centers (?) Method :

90 views • 1 slides

ER+/HER2- subtype (central review by qRT -PCR) N=566 (71.7%)

Figure S2. GEICAM/9906 patients N=1246. P atients with informed consent (IC) for molecular analysis N=1156 (93%). FFPE tumor available in central lab N=800 (69% of total IC). Successful RNA extraction N=789 (98.6%). ER+/HER2- subtype (central review by qRT -PCR) N=566 (71.7%).

155 views • 1 slides